Icahn School of Medicine at Mount Sinai receives $5M NCI grant for NIH Cancer Target Discovery and Development Center

Joseph F. Fraumeni Jr., inventor of molecular epidemiology, was a “gentle giant” who “bet on the good people”
Chanock and Brawley reflect on their illustrious mentor

If a Mount Rushmore of Epidemiology were to exist, Joseph F. Fraumeni Jr. would be etched into the face of the mountain, former NCI Director Ned Sharpless once told Stephen J. Chanock.

The V Foundation announces recipients of the 2026 Breaking Barriers in Cancer Research Award

The V Foundation for Cancer Research, a top-rated cancer research charity, announced $11.2 million in funding awarded to 14 scientists through its 2026 Breaking Barriers in Cancer Research Award program.

July 24, 2026

Vol.52 No.29

In Brief

Sylvester’s Marlon Wong receives Gabrielle’s Angel Foundation grant to study CIPN

Marlon L. Wong, associate professor of clinical physical therapy at the University of Miami Miller School of Medicine, was awarded a grant from Gabrielle’s Angel Foundation for Cancer Research. The three-year, $225,000 award will support research focused on improving quality of life for patients living with chemotherapy-induced peripheral neuropathy and other long-term effects of cancer treatment.

July 24, 2026

Vol.52 No.29

Funding Opportunities

Binaytara invites abstract applications for National Summit on Hematologic Cancers’ Hematologic Innovation Challenge

Early-career hematologists will have the opportunity to compete for a share of $250,000 in research funding at Binaytara’s 2026 National Summit on Hematologic Cancers to be held Oct. 16-17 at Music City Center in Nashville, TN.

July 17, 2026

Vol.52 No.28

Capitol Hill

OMB’s plan to increase political control of science faces stiff opposition on Capitol Hill

The Trump administration has a fight on its hands as it pushes forward with a plan to exert greater political control over government funding of science.

July 10, 2026

Vol.52 No.27

By Paul Goldberg

The long life of a clinical trial
How JCO sustains landmark oncology research

In modern oncology, important insights from clinical trials often emerge years after initial publication. As new therapies extend survival and transition more patients into long-term remissions, clinicians and researchers are increasingly looking beyond initial response rates to understand durability, long-term safety, and even the possibility of a cure.

July 10, 2026

Vol.52 No.27

By Journal of Clinical Oncology

Icahn School of Medicine at Mount Sinai receives $5M NCI grant for NIH Cancer Target Discovery and Development Center

YOU MAY BE INTERESTED IN

Joseph F. Fraumeni Jr., inventor of molecular epidemiology, was a “gentle giant” who “bet on the good people”
Chanock and Brawley reflect on their illustrious mentor

The V Foundation announces recipients of the 2026 Breaking Barriers in Cancer Research Award

Sylvester’s Marlon Wong receives Gabrielle’s Angel Foundation grant to study CIPN

Binaytara invites abstract applications for National Summit on Hematologic Cancers’ Hematologic Innovation Challenge

OMB’s plan to increase political control of science faces stiff opposition on Capitol Hill

The long life of a clinical trial
How JCO sustains landmark oncology research

Renew today!

Subscriber content

Never miss an issue!

Login

Icahn School of Medicine at Mount Sinai receives $5M NCI grant for NIH Cancer Target Discovery and Development Center

YOU MAY BE INTERESTED IN

Joseph F. Fraumeni Jr., inventor of molecular epidemiology, was a “gentle giant” who “bet on the good people”Chanock and Brawley reflect on their illustrious mentor

The V Foundation announces recipients of the 2026 Breaking Barriers in Cancer Research Award

Sylvester’s Marlon Wong receives Gabrielle’s Angel Foundation grant to study CIPN

Binaytara invites abstract applications for National Summit on Hematologic Cancers’ Hematologic Innovation Challenge

OMB’s plan to increase political control of science faces stiff opposition on Capitol Hill

The long life of a clinical trialHow JCO sustains landmark oncology research

Never miss an issue!

Login

Joseph F. Fraumeni Jr., inventor of molecular epidemiology, was a “gentle giant” who “bet on the good people”
Chanock and Brawley reflect on their illustrious mentor

The long life of a clinical trial
How JCO sustains landmark oncology research